Skip to main content

Table 4 Multivariate analyses using the Cox proportional hazard method. Evaluation of prognostic impact of number of metastatic nodes, pN, nodal ratio and LODDS

From: Prognostic role of nodal ratio, LODDS, pN in patients with pancreatic cancer with venous involvement

Variable

b

SE

P

Exp (b)

95% CI

Age

−0.100

0.184

0.585

0.905

0.633 to 1.294

Sex

−0.244

0.188

0.196

0.784

0.543 to 1.132

Tumor size

0.176

0.197

0.372

1.192

0.813 to 1.749

R status

−0.089

0.221

0.686

0.915

0.594 to 1.407

T stage

−0.059

0.193

0.759

0.942

0.646 to 1.374

N. met. Nodes

0.427

0.186

0.022

1.533

1.066 to 2.23

Age

−0.013

0.183

0.945

0.987

0.691 to 1.411

Sex

−0.247

0.189

0.192

0.781

0.540 to 1.130

Tumor size

0.190

0.197

0.336

1.209

0.823 to 1.775

R status

−0.085

0.218

0.698

0.919

0.600 to 1.407

T stage

−0.115

0.195

0.555

0.892

0.610 to 1.303

N stage

0.603

0.239

0.011

1.828

1.148 to 2.911

Age

−0.0812

0.183

0.655

0.922

0.646 to 1.316

Sex

−0.195

0.190

0.305

0.823

0.568 to 1.192

Tumor size

0.206

0.196

0.293

1.229

0.838 to 1.803

R status

−0.170

0.221

0.441

0.843

0.548 to 1.298

T stage

−0.019

0.188

0.920

0.981

0.680 to 1.416

Nodal ratio

0.384

0.108

0.001

1.468

1.189 to 1.811

Age

−0.010

0.183

0.955

0.989

0.692 to 1.415

Sex

−0.229

0.188

0.221

0.795

0.551 to 1.146

Tumor size

0.184

0.197

0.349

1.202

0.819 to 1.764

R status

−0.189

0.222

0.395

0.828

0.537 to 1.277

T stage

−0.114

0.197

0.563

0.892

0.608 to 1.310

LODDS

0.273

0.089

0.002

1.313

1.105 to 1.562

  1. N. met. Nodes number of metastatic nodes, NR nodal ratio, LODDS log odds of positive lymph nodes